Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurodevelopmental outcome after standard-dose sevoflurane versus low-dose sevoflurane + dexmedetomidine + remifentanil anesthesia in young children
2017-002803-81Phase 3Active
- Sponsor
- Istituto Giannina Gaslini
- Start
- Aug 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sevoflurane, dexmedetomidine and remifentanil in None (2 arms), sponsored by Istituto Giannina Gaslini. Primary endpoint: Full-scale IQ score of the Wechsler Preschool and Primary School Intelligence Scale. Started Aug 2021; status: active.
02
Drugs
sevofluranedexmedetomidineremifentanil
Beyond the preview
Go deeper on 2017-002803-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002803-81.